Acumen Pharmaceuticals Inc (ABOS)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -209.943 | -28.309 | -73.232 | -20.077 | -20.671 |
| Return on Equity (%) | 134.606 | 48.815 | -97.396 | -20.705 | -22.982 |
| Return on Invested Capital (%) | -267.478 | -36.047 | -16.911 | -24.697 | -30.069 |
| Operating Margin (%) | -465.94 | -510.097 | N/A | N/A | N/A |
| Net Profit Margin (%) | -452.917 | -510.097 | N/A | N/A | N/A |
| Book Value Per Share | 14.272 | 90.84 | 4.663 | 2.726 | 3.099 |
| Earnings Per Share | -18.344 | -17.482 | -2.083 | -0.619 | -0.608 |
| Cash Per Share | 15.637 | 104.48 | 2.53 | 1.879 | 0.776 |
| Working Capital Per Share | 13.928 | 90.84 | 4.007 | 2.491 | 2.712 |
| Operating Profit Per Share | 4.05 | 3.427 | N/A | N/A | N/A |
| EBIT Per Share | -18.871 | -17.482 | -2.083 | -0.619 | -0.608 |
| EBITDA Per Share | -18.871 | -17.482 | -2.083 | -0.619 | -0.608 |
| Free Cash Flow Per Share | -18.344 | -17.482 | -2.083 | -0.617 | -0.608 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | 5.349 | 6.978 | 38.597 | 23.084 | 19.013 |
| Quick Ratio | 4.905 | 6.893 | 37.738 | 22.735 | 18.774 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 419k | 419k | 20.06M | 41.03M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | N/A | N/A | 41.03M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 16.406 | N/A | N/A | N/A | 30.197 |
| Quick Ratio | N/A | N/A | N/A | 15.994 | N/A | N/A | N/A | 29.805 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 176.03M |
| Price to Earnings Ratio | -3.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.58 |
| Price to Book Ratio | 0.65 |
| Dividend Yield | - |
| Shares Outstanding | 60.08M |
| Average Volume (1 week) | 600.97k |
| Average Volume (1 Month) | 479.31k |
| 52 Week Change | -61.95% |
| 52 Week High | 7.98 |
| 52 Week Low | 1.8101 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
